about
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Read More
34.09
0.22
(0.65%)
262.3K
XNAS Volume
XNAS 04 Jun, 2026 12:20 PM (EDT)
Board Meeting
The board meeting for Kodiak Sciences Inc is scheduled for today, for the purpose of Jefferies Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Kodiak Sciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..